Health Catalyst (HCAT) Return on Sales (2018 - 2026)

Health Catalyst's Return on Sales history runs 9 years deep, the most recent figure standing at 0.02% for Q1 2026.

• Quarterly Return on Sales fell 1.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (down 1.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Sales was 0.02% for Q1 2026 at Health Catalyst, down from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q2 2024 and bottomed at 0.02% in Q1 2026.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales changed 0 bps — and 2025, when it fell 1 bps.
• Health Catalyst's Return on Sales stood at 0.01% in 2022, then increased by 22 bps to 0.0% in 2023, then soared by 36 bps to 0.0% in 2024, then plunged by 369 bps to 0.01% in 2025, then fell by 29 bps to 0.02% in 2026.
• Business Quant data shows HCAT's Return on Sales at 0.02% in Q1 2026, 0.01% in Q4 2025, and 0.0% in Q3 2025.